Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
Toxins · 2023
DOI: 10.3390/toxins15040276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2023. Verfasst von Carolla El Chamieh und 15 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, 948…. Hauptthemen laut MEDLINE: Uremia, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche.
Abstract (Originalsprache)
Use of proton-pump inhibitors (PPIs) is common in patients with chronic kidney disease (CKD). PPIs and many uremic toxins (UTs) are eliminated by the kidney’s tubular organic anion transporter system. In a cross-sectional study, we sought to evaluate the association between PPI prescription and serum concentrations of various UTs. We studied a randomly selected sub-group of participants in the CKD-REIN cohort (adult patients with a confirmed diagnosis of CKD and estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2) with available frozen samples collected at baseline. PPI prescription was recorded at baseline. Serum concentrations of 10 UTs were measured using a validated liquid chromatography tandem mass spectrometry technique. Multiple linear regression was performed, with the log UT concentration as the dependent variable. Of the 680 included patients (median age: 68 years; median eGFR: 32 mL/min/1.73 m2), 31% had PPI prescriptions at baseline. Patients using PPIs had higher levels of certain UTs in comparison to other patients, including total and free indoxyl sulfate (IS), total and free p-cresylsulfate, total and free p-cresylglucuronide (PCG), phenylacetylglutamine (PAG), free kynurenine, and free hippuric acid. After adjustment for baseline co-morbidities, number of co-prescribed drugs, and laboratory data, including eGFR, associations between PPI prescription and elevated serum concentrations of free and total IS, free and total PCG, and PAG remained significant. Our results indicate that PPI prescription is independently associated with serum UT retention. These findings are interesting to better understand the factors that may modulate serum UT concentration in CKD patients, however, they will need to be confirmed by longitudinal studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, 94807 Villejuif, France.
- Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France.
- UVSQ, Université Paris-Saclay, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, 78180 Montigny-le-Bretonneux, France.
- Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Medical Center, 80054 Amiens, France.
- MP3CV Laboratory, Jules Verne University of Picardie, F-80054 Amiens, France.
- Biomedecine Agency, 93210 Saint Denis La Plaine, France.
ORCID-Profile: Carolla El Chamieh, Islam Amine Larabi, Solène M Laville, Christian Jacquelinet, Christian Combe, Jean-Claude Alvarez, Sophie Liabeuf
Förderung
- Agence Nationale de la Recherche
Zitieren
APA
El Chamieh, C., Larabi, I. A., Laville, S. M., Jacquelinet, C., Combe, C., Fouque, D., Laville, M., Frimat, L., Pecoits-Filho, R., Lange, C., Stengel, B., Alencar De Pinho, N., Alvarez, J. C., Massy, Z. A., Liabeuf, S., & Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group (2023). Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease. Toxins. https://doi.org/10.3390/toxins15040276
Vancouver
El Chamieh C, Larabi IA, Laville SM, Jacquelinet C, Combe C, Fouque D, et al. Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease. Toxins. 2023. doi:10.3390/toxins15040276
BibTeX
@article{ElChamieh2023,
author = {El Chamieh, Carolla and Larabi, Islam Amine and Laville, Solène M and Jacquelinet, Christian and Combe, Christian and Fouque, Denis and Laville, Maurice and Frimat, Luc and Pecoits-Filho, Roberto and Lange, Céline and Stengel, Bénédicte and Alencar De Pinho, Natalia and Alvarez, Jean-Claude and Massy, Ziad A and Liabeuf, Sophie and Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group, Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group},
title = {Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease},
journal = {Toxins},
year = {2023},
doi = {10.3390/toxins15040276}
}
EUVIMED